z-logo
open-access-imgOpen Access
Ropivacaine represses the ovarian cancer cell stemness and facilitates cell ferroptosis through inactivating the PI3K/AKT signaling pathway
Author(s) -
Yi Lu,
Jinbao Mao,
Yanbing Xu,
Hao Pan,
Yu Wang,
Wei Li
Publication year - 2022
Publication title -
human and experimental toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.572
H-Index - 78
eISSN - 1477-0903
pISSN - 0960-3271
DOI - 10.1177/09603271221120652
Subject(s) - pi3k/akt/mtor pathway , protein kinase b , cancer research , signal transduction , ropivacaine , cell growth , medicine , stem cell , cell , biology , pharmacology , microbiology and biotechnology , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom